NASDAQ Biotechnology Index (NBI) Companies by Market Cap
The NASDAQ Biotechnology Index (NBI) tracks 263 constituent companies with a combined market cap of $1.84 Trillion, covering the largest publicly traded companies in USA. This ranking lists all NBI index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$1.84 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 101 |
Nurix Therapeutics Inc
NASDAQ:NRIX |
% | $1.93 Billion | Healthcare | Biotechnology | $22.35 | +0.63% |
| 102 |
Agios Pharm
NASDAQ:AGIO |
% | $1.90 Billion | Healthcare | Biotechnology | $31.81 | -0.34% |
| 103 |
Galapagos NV ADR
NASDAQ:GLPG |
% | $1.89 Billion | Healthcare | Biotechnology | $28.68 | -1.58% |
| 104 |
Sarepta Therapeutics Inc
NASDAQ:SRPT |
% | $1.89 Billion | Healthcare | Biotechnology | $17.85 | -1.98% |
| 105 |
Vir Biotechnology Inc
NASDAQ:VIR |
% | $1.88 Billion | Healthcare | Biotechnology | $11.70 | +5.22% |
| 106 |
Mesoblast Ltd
NASDAQ:MESO |
% | $1.86 Billion | Healthcare | Biotechnology | $14.29 | +3.93% |
| 107 |
Recursion Pharmaceuticals Inc
NASDAQ:RXRX |
% | $1.84 Billion | Healthcare | Biotechnology | $4.36 | +10.38% |
| 108 |
Trevi Therapeutics Inc
NASDAQ:TRVI |
% | $1.83 Billion | Healthcare | Biotechnology | $13.19 | +2.85% |
| 109 |
Structure Therapeutics Inc. American Depositary Shares
NASDAQ:GPCR |
% | $1.82 Billion | Healthcare | Biotechnology | $25.54 | -0.51% |
| 110 |
UroGen Pharma Ltd
NASDAQ:URGN |
% | $1.80 Billion | Healthcare | Biotechnology | $36.83 | -0.41% |
| 111 |
Zymeworks Inc. Common Stock
NASDAQ:ZYME |
% | $1.79 Billion | Healthcare | Biotechnology | $25.79 | +2.10% |
| 112 |
Dynavax Technologies Corporation
NASDAQ:DVAX |
% | $1.76 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $15.50 | +0.00% |
| 113 |
Vericel Corp Ord
NASDAQ:VCEL |
% | $1.73 Billion | Healthcare | Biotechnology | $40.10 | +0.12% |
| 114 |
Personalis Inc
NASDAQ:PSNL |
% | $1.71 Billion | Healthcare | Diagnostics & Research | $16.00 | -0.37% |
| 115 |
Novocure Ltd
NASDAQ:NVCR |
% | $1.69 Billion | Healthcare | Medical Devices | $14.58 | +2.53% |
| 116 |
ANI Pharmaceuticals Inc
NASDAQ:ANIP |
% | $1.66 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $73.89 | +2.65% |
| 117 |
Ocular Therapeutix Inc
NASDAQ:OCUL |
% | $1.66 Billion | Healthcare | Biotechnology | $7.54 | +0.40% |
| 118 |
Stoke Therapeutics Inc
NASDAQ:STOK |
% | $1.60 Billion | Healthcare | Biotechnology | $24.74 | +3.30% |
| 119 |
Intellia Therapeutics Inc
NASDAQ:NTLA |
% | $1.54 Billion | Healthcare | Biotechnology | $13.07 | +3.73% |
| 120 |
Innoviva Inc
NASDAQ:INVA |
% | $1.53 Billion | Healthcare | Biotechnology | $21.21 | +1.63% |
| 121 |
Syndax Pharmaceuticals Inc
NASDAQ:SNDX |
% | $1.52 Billion | Healthcare | Biotechnology | $16.99 | +0.53% |
| 122 |
Immunocore Holdings Ltd
NASDAQ:IMCR |
% | $1.50 Billion | Healthcare | Biotechnology | $29.39 | +1.03% |
| 123 |
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP |
% | $1.47 Billion | Healthcare | Biotechnology | $30.65 | +2.68% |
| 124 |
Taysha Gene Therapies Inc
NASDAQ:TSHA |
% | $1.46 Billion | Healthcare | Biotechnology | $4.49 | +1.35% |
| 125 |
Ultragenyx
NASDAQ:RARE |
% | $1.41 Billion | Healthcare | Biotechnology | $15.48 | +1.24% |
| 126 |
Absci Corp
NASDAQ:ABSI |
% | $1.41 Billion | Healthcare | Biotechnology | $10.16 | +13.65% |
| 127 |
Uniqure NV
NASDAQ:QURE |
% | $1.41 Billion | Healthcare | Biotechnology | $22.59 | +0.22% |
| 128 |
Omeros Corporation
NASDAQ:OMER |
% | $1.40 Billion | Healthcare | Biotechnology | $19.83 | +3.71% |
| 129 |
Xeris Pharmaceuticals Inc
NASDAQ:XERS |
% | $1.40 Billion | Healthcare | Biotechnology | $10.48 | +2.85% |
| 130 |
AnaptysBio Inc
NASDAQ:ANAB |
% | $1.36 Billion | Healthcare | Biotechnology | $45.95 | -0.56% |
| 131 |
Compass Pathways Plc
NASDAQ:CMPS |
% | $1.34 Billion | Healthcare | Medical Care Facilities | $12.00 | +4.62% |
| 132 |
Novavax Inc
NASDAQ:NVAX |
% | $1.31 Billion | Healthcare | Biotechnology | $12.75 | +15.80% |
| 133 |
Inhibrx Biosciences, Inc.
NASDAQ:INBX |
% | $1.30 Billion | Healthcare | Biotechnology | $95.01 | +2.43% |
| 134 |
Oric Pharmaceuticals Inc
NASDAQ:ORIC |
% | $1.24 Billion | Healthcare | Biotechnology | $11.99 | -0.33% |
| 135 |
Tourmaline Bio Inc.
NASDAQ:TRML |
% | $1.23 Billion | Healthcare | Biotechnology | $47.98 | +0.00% |
| 136 |
Day One Biopharmaceuticals Inc
NASDAQ:DAWN |
% | $1.13 Billion | Healthcare | Biotechnology | $21.53 | +0.00% |
| 137 |
Maravai Lifesciences Holdings Inc
NASDAQ:MRVI |
% | $1.11 Billion | Healthcare | Biotechnology | $7.44 | +3.19% |
| 138 |
Harrow Health Inc
NASDAQ:HROW |
% | $1.10 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $29.36 | -3.80% |
| 139 |
Tyra Biosciences Inc
NASDAQ:TYRA |
% | $1.07 Billion | Healthcare | Biotechnology | $19.94 | -0.15% |
| 140 |
MannKind Corp
NASDAQ:MNKD |
% | $1.06 Billion | Healthcare | Biotechnology | $3.29 | -3.80% |
| 141 |
Iovance Biotherapeutics Inc
NASDAQ:IOVA |
% | $1.03 Billion | Healthcare | Biotechnology | $14.62 | +9.84% |
| 142 |
MeiraGTx Holdings PLC
NASDAQ:MGTX |
% | $1.03 Billion | Healthcare | Biotechnology | $10.69 | +1.81% |
| 143 |
Pacira BioSciences, Inc.
NASDAQ:PCRX |
% | $1.02 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $36.31 | -0.22% |
| 144 |
Savara Inc
NASDAQ:SVRA |
% | $1.01 Billion | Healthcare | Biotechnology | $4.92 | +1.86% |
| 145 |
Castle Biosciences Inc
NASDAQ:CSTL |
% | $1.00 Billion | Healthcare | Diagnostics & Research | $34.42 | +2.11% |
| 146 |
Verve Therapeutics Inc
NASDAQ:VERV |
% | $994.04 Million | Healthcare | Biotechnology | $11.13 | +0.00% |
| 147 |
Amphastar P
NASDAQ:AMPH |
% | $980.07 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $26.62 | +3.14% |
| 148 |
Fortrea Holdings Inc.
NASDAQ:FTRE |
% | $948.95 Million | Healthcare | Biotechnology | $20.84 | +2.31% |
| 149 |
Kura Oncology Inc
NASDAQ:KURA |
% | $935.87 Million | Healthcare | Biotechnology | $10.60 | +0.76% |
| 150 |
Alumis Inc
NASDAQ:ALMS |
% | $902.16 Million | Healthcare | Biotechnology | $7.16 | +2.73% |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices